However, for a disease where current treatments remain unable to fully prevent progression or restore function, the peptide research pipeline offers genuine reasons for cautious optimism
They have not been reviewed, evaluated, or approved by regulatory authorities for the diagnosis, treatment, cure, or prevention of any disease or medical condition
Clinical Application: Cagrilintide is actively used in clinical trials to further assess its efficacy in treating obesity, overweight conditions, and related metabolic disorders
Transepidermal water loss (TEWL) measurements in rosacea skin are consistently elevated compared to healthy controls, indicating that the barrier is already operating in a compromised state
Additionally, the CCK-8 assay was used to evaluate the effect of FOXO4-DRI treatment on cell viability